EISAI
LIVE

Serial Number

98256766

Owner

EISAI R&D MANAGEMENT CO., LTD.

Attorney

Caroline H. Mead

Filing Date

Nov 6, 2023

Add to watchlist:

No watchlists yet
View on USPTO

EISAI Trademark

Serial Number: 98256766 • Registration: 7877658

EISAI is a trademark filed by EISAI R&D MANAGEMENT CO., LTD. on November 6, 2023. The trademark is classified under Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

EISAI R&D MANAGEMENT CO., LTD. (221 trademarks)

6-10, KOISHIKAWA 4-CHOME, BUNKYO-KU
TOKYO , JP

Entity Type: 03

Trademark Details

Filing Date

November 6, 2023

Registration Date

August 5, 2025

Published for Opposition

July 30, 2024

Goods & Services

Downloadable mobile applications and computer software for providing information on health and wellness; Downloadable mobile applications and computer software for analyzing and evaluation of cognitive functions; Downloadable mobile applications and computer software for recording, storing and transmitting personal information, health management data, daily life data and medical data; Downloadable mobile applications and computer software for electronical interaction between doctors, medical care centers, healthcare professionals and patients; Downloadable mobile applications and computer software for patient monitoring and compliance management; Downloadable mobile applications and computer software for supporting patients and their care partners; Downloadable electronic publications in the nature of booklets, workbooks, guides, pamphlets or brochures in the field of health and wellness; Downloadable electronic publications in the nature of booklets, workbooks, guides, pamphlets or brochures in the field of neurology, Alzheimer's disease and related disorders, cognitive impairment and dementia; Downloadable electronic publications in the nature of booklets, workbooks, guides, pamphlets or brochures in the field of oncology; Downloadable electronic publications in the nature of booklets, workbooks, guides, pamphlets or brochures in the field of insomnia and other sleep disorders

Pharmaceuticals for treatment of oncological diseases, cancer, and tumors; pharmaceuticals for treatment of neurological diseases, Alzheimer's Disease, cognitive impairment, dementia, and epilepsy; pharmaceuticals for treatment of insomnia and other sleep disorders

Providing healthcare and medical information; Providing information in the fields of health and wellness; Providing medical and health care information and medical advice in connection with patients and relatives support and follow-up programs; Providing medical information and health care information and advice to improve understanding about pharmaceuticals and medical treatments by health care providers, patients, patients' families and hospitals; Providing medical information, health care information and medical advice to cope with the associated symptoms of diseases in the field of oncology, neurology and immunology; Consultancy and information services relating to medical products

Providing online non-downloadable computer programs on data networks for human health care; Providing online non-downloadable computer programs for analyzing and evaluation of cognitive functions; Providing online non-downloadable computer programs on data networks for recording, storing and transmitting personal information, health management data, daily life data and medical data; Providing online non-downloadable computer programs on data networks for electronical interaction between doctors, medical care centers, healthcare professionals and patients; Providing online non-downloadable computer programs on data networks for patient monitoring and compliance management; Providing online non-downloadable computer programs on data networks for supporting patients and their care partners; Scientific research, technological research, digital science research and medical research in the field of oncology, neurology, insomnia, and digital science-based solutions for predicting, protecting and promoting brain health

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Aug 5, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
Aug 5, 2025 R.PR
1(B) BASIS DELETED; PROCEED TO REGISTRATION
Jul 15, 2025 DP1B
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Jul 15, 2025 CHAN
TEAS POST PUBLICATION AMENDMENT RECEIVED
Jul 14, 2025 EPPA
REINSTATEMENT GRANTED - INADVERTENTLY ABANDONED
Jul 9, 2025 RGIA
ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Jun 30, 2025 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Jun 30, 2025 ABN6
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Jun 24, 2025 AITU
NOTICE OF ALLOWANCE CANCELLED
Sep 26, 2024 IUCN
AMENDMENT AFTER NOA NOT ENTERED
Sep 26, 2024 INOA
TEAS DELETE 1(B) BASIS RECEIVED
Sep 26, 2024 D1BR
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Sep 24, 2024 NOAM
TEAS DELETE 1(B) BASIS RECEIVED
Aug 9, 2024 D1BR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 30, 2024 NPUB
PUBLISHED FOR OPPOSITION
Jul 30, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 10, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 25, 2024 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 14, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 14, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 14, 2024 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Mar 27, 2024 GNRN
NON-FINAL ACTION E-MAILED
Mar 27, 2024 GNRT
NON-FINAL ACTION WRITTEN
Mar 27, 2024 CNRT
ASSIGNED TO EXAMINER
Mar 25, 2024 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Dec 5, 2023 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 2, 2023 NWOS
NEW APPLICATION ENTERED
Nov 9, 2023 NWAP